Evidence map›Paper›PMID 38818920›Full record

ReviewCurrent pharmaceutical design2024

Impact of Bioactive Compounds in the Management of Various Inflammatory Diseases.

Ritchu Babbar, Arpanpreet Kaur, Vanya, Rashmi Arora, Jeetendra Kumar Gupta, Pranay Wal, Arpan Kumar Tripathi, Akshada Amit Koparde, Pradeep Goyal, Seema Ramniwas and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Journal of enzyme inhibition and medicinal chemistry · 2026
    Article
  2. Review
  3. Review
  4. Foods (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ritchu BabbarChitkara College of Pharmacy, Chitkara University, Punjab, India.
Arpanpreet KaurChitkara College of Pharmacy, Chitkara University, Punjab, India.
VanyaChitkara College of Pharmacy, Chitkara University, Punjab, India.
Rashmi AroraChitkara College of Pharmacy, Chitkara University, Punjab, India.
Jeetendra Kumar GuptaInstitute of Pharmaceutical Research, GLA University Mathura, Uttar Pradesh, India.
Pranay WalDepartment of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, Uttar Pradesh 209305, India.
Arpan Kumar TripathiKIPS, Shri Shankaracharya Professional University, Bhilai, Chhattisgarh, India.
Akshada Amit KopardeDepartment of Pharmaceutical Chemistry, Krishna Vishwa Vidyapeeth, Krishna Institute of Pharmacy, Malkapur, Karad 415110, Maharashtra, India.
Pradeep GoyalDepartment of Pharmacology, Saraswati College of Pharmacy, Gharuan, Mohali, Punjab, India.
Seema RamniwasUniversity Centre for Research and Development, University of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab, India.
Monica GulatiSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 1444411, India.
Tapan BehlAmity School of Pharmaceutical Sciences, Amity University, Mohali, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is an individual's physiological response to a sequence of physical, chemical, or infectious stressors acting mainly to provide localized protection. Although inflammation is a protective and thus beneficial process, its excess or prolonged action can be harmful to the body. An increasing number of the population worldwide are changing their lifestyles, which leads to a rise in inflammatory diseases, such as atherosclerosis, angina pectoris, myocardial infarction, ulcerative colitis, cancer, and many more. Their treatment is based majorly on the pharmacological approach. However, natural products or bioactive compounds are of great significance in inflammation therapy because they show minimum side effects and maximum bioavailability. Therefore, it is critical to investigate bioactive substances that can modify target functions associated with oxidative stress defense and might be used to achieve various health benefits. This review accentuates the essence of bioactive chemicals used in the treatment of inflammation and other inflammatory illnesses. These bioactive compounds can be of any origin, such as plants, animals, bacteria, fungi, marine invertebrates, etc. Bioactive compounds derived from plant sources, such as glycyrrhizin, lignans, lycopene, resveratrol, indoles, and phenolic and polyphenolic compounds, work mainly by reducing oxidative stress and thereby preventing various inflammatory disorders. A large diversity of these anti-inflammatory bioactive compounds has also been discovered in marine environments, giving rise to an increase in the interest of various scientists in marine invertebrates and microbes. The vast diversity of microbes found in the marine environment represents an enormous supply to extract novel compounds, such as from bacteria, cyanobacteria, fungi, algae, microalgae, tiny invertebrates, etc. In the present review, an attempt has been made to summarize such novel bioactive compounds that help prevent inflammatory responses via different mechanisms of action.

Indexed as

Anti-Inflammatory AgentsBiological ProductsInflammationAnimalsHumansOxidative StressAnti-Inflammatory AgentsBiological Productsanti-inflammatory actionbioactive compoundsInflammationinflammatory diseases.marine-derivedplant-derived

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.